Agios Reports Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Agios Pharma (AGIO) Tops Q3 EPS by 20c
November 1, 2017 7:14 AM EDTAgios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.59), $0.20 better than the analyst estimate of ($1.79). Revenue for the quarter came in at $11.4 million versus the consensus estimate of $9.77 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More